University of Münster
CRIS@UM
DE | EN

Josua Janowski

No current affiliations available for this person. The person is no longer active at the university.

Publications

Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier.
Faist A; Schloer S; Mecate-Zambrano A; Janowski J; Schreiber A; Boergeling Y; Conrad BCG; Kumar S; Toebben L; Schughart K; Baumgardt M; Kessler M; Hoenzke K; Hocke A; Trautmann M; Kato H; Hartmann W; Christersson A; Rescher U; Mellmann A; Kuehn J; Kuempers P; Wolff T; Wiewrodt R; Rovas A; Barth P; Wiebe K; Brunotte L; Ludwig S (2023)
In: Antiviral Research, 209
Type of Publication: Research article (journal)
Glycolytic interference blocks influenza A virus propagation by impairing viral polymerase-driven synthesis of genomic vRNA.
Kleinehr J; Schöfbänker M; Daniel K; Günl F; Mohamed FF; Janowski J; Brunotte L; Boergeling Y; Liebmann M; Behrens M; Gerdemann A; Klotz L; Esselen M; Humpf HU; Ludwig S; Hrincius ER (2023)
In: PLoS Pathogens, 19(7)
Type of Publication: Research article (journal)

Projects

KFO 342 - P6: Disease Tailored Therapeutic Strategies against Hyperinflammatory Viral Infections caused by Highly Pathogenic Respiratory Viruses
Duration: 01/10/2023 - 30/09/2026 | 2nd Funding period
Funded by: DFG - Clinical Research Unit
Type of project: Subproject in DFG-joint project hosted at University of Münster